Susquehanna International Group, LLP Arvinas, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

20 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$23.66 - $32.73 $1.45 Million - $2 Million	-61,100 Reduced 88.17%	8,200 $201,000
Q2 2024 Aug 15, 2024	BUY	$24.46 - $40.4 $237,262 - $391,880	9,700 Added 16.28%	69,300 $1.84 Million
Q1 2024 May 07, 2024	BUY	$36.38 - $52.31 $1.05 Million - $1.51 Million	28,800 Added 93.51%	59,600 $2.46 Million
Q4 2023 Feb 14, 2024	BUY	$14.19 - $42.33 $79,464 - $237,048	5,600 Added 22.22%	30,800 $1.27 Million
Q3 2023 Nov 14, 2023	BUY	$19.64 - $28.21 $151,228 - $217,217	7,700 Added 44.0%	25,200 $494,000
Q2 2023 Aug 11, 2023	SELL	$21.73 - $31.43 $17,384 - $25,144	-800 Reduced 4.37%	17,500 $434,000
Q1 2023 May 16, 2023	SELL	$26.15 - $37.26 $1.02 Million - $1.45 Million	-38,900 Reduced 68.01%	18,300 $499,000
Q4 2022 Feb 14, 2023	BUY	$32.47 - $57.24 $1.25 Million - $2.21 Million	38,600 Added 207.53%	57,200 $1.96 Million
Q3 2022 Nov 14, 2022	SELL	$41.87 - $57.99 $213,537 - $295,749	-5,100 Reduced 21.52%	18,600 $828,000
Q2 2022 Aug 15, 2022	SELL	$36.01 - $74.24 $1.67 Million - $3.45 Million	-46,500 Reduced 66.24%	23,700 $998,000
Q1 2022 May 16, 2022	SELL	$60.27 - $81.57 $307,377 - $416,006	-5,100 Reduced 6.77%	70,200 $4.72 Million
Q4 2021 Feb 14, 2022	BUY	$65.85 - $96.21 $217,304 - $317,493	3,300 Added 4.58%	75,300 $6.19 Million
Q3 2021 Nov 15, 2021	SELL	$73.2 - $107.87 $270,840 - $399,119	-3,700 Reduced 4.89%	72,000 $5.92 Million
Q2 2021 Aug 11, 2021	SELL	$60.45 - $84.26 $368,745 - $513,986	-6,100 Reduced 7.46%	75,700 $5.83 Million
Q1 2021 May 17, 2021	SELL	$58.19 - $91.37 $4.24 Million - $6.65 Million	-72,800 Reduced 47.09%	81,800 $5.41 Million
Q4 2020 Feb 16, 2021	BUY	$20.19 - $84.93 $2.85 Million - $12 Million	141,200 Added 1053.73%	154,600 $13.1 Million
Q3 2020 Nov 16, 2020	SELL	$22.99 - $36.34 $643,720 - $1.02 Million	-28,000 Reduced 67.63%	13,400 $316,000
Q2 2020 Aug 14, 2020	BUY	$29.88 - $56.74 $313,740 - $595,770	10,500 Added 33.98%	41,400 $1.39 Million
Q1 2020 May 15, 2020	SELL	$33.0 - $54.5 $118,800 - $196,200	-3,600 Reduced 10.43%	30,900 $1.25 Million
Q4 2019 Feb 14, 2020	BUY	$15.39 - $44.38 $530,955 - $1.53 Million	34,500 New	34,500 $1.42 Million

Others Institutions Holding ARVN

# of Institutions

229

Shares Held

68.4M

Call Options Held

226K

Put Options Held

285K

Vanguard Group Inc Valley Forge, PA

7.01M
Shares

$176 Million
0.0% of portfolio
Eco R1 Capital, LLC San Francisco, CA

6.73M
Shares

$169 Million
7.19% of portfolio
Black Rock Inc. New York, NY

6.26M
Shares

$157 Million
0.0% of portfolio
Price T Rowe Associates Inc Baltimore, MD

3.85M
Shares

$96.8 Million
0.01% of portfolio
Rtw Investments, LP New York, NY

2.78M
Shares

$69.9 Million
1.09% of portfolio

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $1.34B
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account